LFCR
Price
$7.01
Change
+$0.20 (+2.94%)
Updated
Sep 26 closing price
Capitalization
262.64M
4 days until earnings call
SHPH
Price
$4.01
Change
-$0.13 (-3.14%)
Updated
Sep 26 closing price
Capitalization
4.29M
Interact to see
Advertisement

LFCR vs SHPH

Header iconLFCR vs SHPH Comparison
Open Charts LFCR vs SHPHBanner chart's image
Lifecore Biomedical
Price$7.01
Change+$0.20 (+2.94%)
Volume$262.61K
Capitalization262.64M
Shuttle Pharmaceuticals Holdings
Price$4.01
Change-$0.13 (-3.14%)
Volume$74.05K
Capitalization4.29M
LFCR vs SHPH Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. SHPH commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a StrongBuy and SHPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (LFCR: $7.01 vs. SHPH: $4.01)
Brand notoriety: LFCR and SHPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 192% vs. SHPH: 125%
Market capitalization -- LFCR: $262.64M vs. SHPH: $4.29M
LFCR [@Pharmaceuticals: Generic] is valued at $262.64M. SHPH’s [@Pharmaceuticals: Generic] market capitalization is $4.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileSHPH’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • SHPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFCR and SHPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 5 TA indicator(s) are bullish while SHPH’s TA Score has 6 bullish TA indicator(s).

  • LFCR’s TA Score: 5 bullish, 4 bearish.
  • SHPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SHPH is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -10.93% price change this week, while SHPH (@Pharmaceuticals: Generic) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($263M) has a higher market cap than SHPH($4.29M). LFCR YTD gains are higher at: -5.653 vs. SHPH (-81.327). LFCR has higher annual earnings (EBITDA): -8.81M vs. SHPH (-11.67M). LFCR has more cash in the bank: 8.27M vs. SHPH (4.82M). SHPH has less debt than LFCR: SHPH (713K) vs LFCR (131M). LFCR has higher revenues than SHPH: LFCR (129M) vs SHPH (0).
LFCRSHPHLFCR / SHPH
Capitalization263M4.29M6,125%
EBITDA-8.81M-11.67M75%
Gain YTD-5.653-81.3277%
P/E Ratio51.23N/A-
Revenue129M0-
Total Cash8.27M4.82M172%
Total Debt131M713K18,373%
FUNDAMENTALS RATINGS
LFCR: Fundamental Ratings
LFCR
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LFCRSHPH
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLMMF38.80N/A
N/A
Holmen AB
BGLAF10.42N/A
N/A
Biogaia AB
CZBS46.00-0.05
-0.11%
Citizens Bancshares Corp.
WUXAY13.89-0.32
-2.25%
Wuxi Apptec Co Ltd.
POSAF0.05N/A
-4.15%
Posabit Systems Corporation

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and NBIX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and NBIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.94%
NBIX - LFCR
32%
Poorly correlated
+0.79%
SHPH - LFCR
31%
Poorly correlated
-3.26%
ALKS - LFCR
30%
Poorly correlated
+2.80%
AMRX - LFCR
29%
Poorly correlated
+1.56%
TKNO - LFCR
25%
Poorly correlated
+4.84%
More

SHPH and

Correlation & Price change

A.I.dvisor tells us that SHPH and LFCR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPH and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPH
1D Price
Change %
SHPH100%
-3.26%
LFCR - SHPH
31%
Poorly correlated
+2.94%
PLSH - SHPH
24%
Poorly correlated
-13.64%
IPSEF - SHPH
20%
Poorly correlated
N/A
LIEN - SHPH
20%
Poorly correlated
+0.50%
BFRI - SHPH
11%
Poorly correlated
-0.02%
More